238 related articles for article (PubMed ID: 29891250)
1. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
Feng C; Liu Y; Wang L; Niu D; Han B
Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Gupta H; Parihar S; Tripathi VD
Cureus; 2022 May; 14(5):e25349. PubMed ID: 35761910
[TBL] [Abstract][Full Text] [Related]
3. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
4. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI.
Chen GX; Wang HN; Zou JL; Yuan XX
World J Emerg Med; 2020; 11(3):157-163. PubMed ID: 32351648
[TBL] [Abstract][Full Text] [Related]
6. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Geng N; Ren L; Xu L; Zou D; Pang W
BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
[No Abstract] [Full Text] [Related]
9. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction.
Lee HC; An SG; Choi JH; Lee TK; Kim J; Kim JH; Chun KJ; Hong TJ; Shin YW; Lee SK
Circ J; 2008 Sep; 72(9):1425-9. PubMed ID: 18724016
[TBL] [Abstract][Full Text] [Related]
10. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.
Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD
J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
13. Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction: a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction.
Yan HB; Wang J; Li N; Zhu XL; Gao H; Ai H; Li X; Ye M; Chi YP; Zhang H
Chin Med J (Engl); 2007 Apr; 120(7):557-61. PubMed ID: 17442202
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction.
Zhao YJ; Fu XH; Ma XX; Wang DY; Dong QL; Wang YB; Li W; Xing K; Gu XS; Jiang YF
Exp Ther Med; 2013 Aug; 6(2):479-484. PubMed ID: 24137212
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction].
Tong ZC; Li Q; Chen M; Miao GB; Wei Y; Li FO; Zhao H; Zhang JJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Oct; 41(10):839-44. PubMed ID: 24377889
[TBL] [Abstract][Full Text] [Related]
16. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial.
Zhang W; Dai J; Zheng X; Xu K; Yang X; Shen L; Wang X; Hao Z; Qiu X; Jiang L; Shi H; Shen L; He B
Medicine (Baltimore); 2021 Apr; 100(15):e25551. PubMed ID: 33847683
[TBL] [Abstract][Full Text] [Related]
18. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
19. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
[TBL] [Abstract][Full Text] [Related]
20. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial.
Choe JC; Oh JH; Lee HC; Lee JW; Park TS; Park JH; Kim E; Kim MS; Ahn J; Park JS; Lee HW; Choi JH; Cha KS
Acta Cardiol; 2023 Oct; 78(8):880-888. PubMed ID: 36942830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]